A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

Clinical trial NCT04766892 · COMPLETED

Trial details

NCT number: NCT04766892
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Heart Failure With Preserved Ejection Fraction

Start date: 2021-03-30
Primary completion: 2024-02-26
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.